Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roel Vink

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|May 17, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsRoel Vink, Maaike Sohne
Nederlands Tijdschrift Voor Geneeskunde|November 12, 2015
[Not Available]Roel Vink, Menno V Huisman
The New England Journal of Medicine|January 7, 2016
Bridging Anticoagulation in Patients with Atrial FibrillationRoel Vink, Maaike Sohne, Menno V Huisman
Wiener Medizinische Wochenschrift (1946)|December 3, 2003
Prevention and treatment of bleeding by pro-hemostatic treatment strategiesMarcel Levi, Roel Vink, Evert de Jonge
International Journal of Hematology|November 15, 2002
Management of bleeding disorders by prohemostatic therapyMarcel M Levi, Roel Vink, Evert de Jonge
Archives of Internal Medicine|December 15, 2004
Low-molecular-weight heparin as bridging anticoagulationCarlo J van Dongen, Roel Vink, Marcel Levi
Hematology (Amsterdam, Netherlands)|February 18, 2004
Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationRoel Vink, Renée B A Van Den Brink, Marcel Levi
Expert Review of Cardiovascular Therapy|May 11, 2007
Challenges in managing anticoagulant therapy in patients with heart valve prosthesesRoel Vink, Pieter-Willem Kamphuisen, Renée B van den Brink, et al.
Archives of Internal Medicine|December 10, 2003
Recurrent thromboembolism after treatment with vitamin K antagonistsCarlo J van Dongen, Roel Vink, Barbara A Hutten, et al.
Archives of Internal Medicine|June 11, 2003
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysisCarlo J J van Dongen, Roel Vink, Barbara A Hutten, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|May 17, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsRoel Vink, Maaike Sohne
Nederlands Tijdschrift Voor Geneeskunde|November 12, 2015
[Not Available]Roel Vink, Menno V Huisman
The New England Journal of Medicine|January 7, 2016
Bridging Anticoagulation in Patients with Atrial FibrillationRoel Vink, Maaike Sohne, Menno V Huisman
Wiener Medizinische Wochenschrift (1946)|December 3, 2003
Prevention and treatment of bleeding by pro-hemostatic treatment strategiesMarcel Levi, Roel Vink, Evert de Jonge
International Journal of Hematology|November 15, 2002
Management of bleeding disorders by prohemostatic therapyMarcel M Levi, Roel Vink, Evert de Jonge
Archives of Internal Medicine|December 15, 2004
Low-molecular-weight heparin as bridging anticoagulationCarlo J van Dongen, Roel Vink, Marcel Levi
Hematology (Amsterdam, Netherlands)|February 18, 2004
Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillationRoel Vink, Renée B A Van Den Brink, Marcel Levi
Expert Review of Cardiovascular Therapy|May 11, 2007
Challenges in managing anticoagulant therapy in patients with heart valve prosthesesRoel Vink, Pieter-Willem Kamphuisen, Renée B van den Brink, et al.
Archives of Internal Medicine|December 10, 2003
Recurrent thromboembolism after treatment with vitamin K antagonistsCarlo J van Dongen, Roel Vink, Barbara A Hutten, et al.
Archives of Internal Medicine|June 11, 2003
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysisCarlo J J van Dongen, Roel Vink, Barbara A Hutten, et al.
Pageof 2